Pharmacological Attenuation of Electroconvulsive Therapy-Induced Cognitive Deficits: Theoretical Background and Clinical Findings
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Electroconvulsive therapy (ECT) is an effective treatment for depression and other psychiatric disorders. However, the practice of ECT is limited by memory and nonmemory cognitive adverse effects. Technical strategies such as a preference for unilateralover bilateral ECT and low-dose over high-dose stimulation reduce these cognitive adverse effects but may also be associated with lesser treatment efficacy or slower treatment response. This article therefore reviews the use of psychopharmacological agents in the attenuation of ECT-induced cognitive deficits with 2 objectives: the identification of implicated mechanisms and the identification of putative efficacy in both animal and human studies. Drugs examined include N-methyl-d-aspartate receptor antagonists, cyclooxygenase inhibitors, calcium channel blockers, cholinesterase inhibitors, glucocorticoid receptor antagonists, thyroid hormones, opioid antagonists, NO donors, nootropic agents, and other medications. Although the clinical data at present are sparse and inconsistent, many recently opened lines of research improve our understanding of the mechanisms involved as well as suggest possible avenues for the testing of new treatments with the potential to attenuate the cognitive adverse effects of ECT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collingridge, G. L., Kehl, S. J., & McLennan, H. (1983) · The Journal of Physiology · doi:10.1113/jphysiol.1983.sp014478 · Cited by 2,413
Acute cortisone administration impairs retrieval of long-term declarative memory in humans
de Quervain, D. J.-F., Roozendaal, B., Nitsch, R. M., McGaugh, J. L., & Hock, C. (2000) · Nature Neuroscience · doi:10.1038/73873 · Cited by 745 · cited 1×
“Acute stress and brief increases in glucocorticoid levels can enhance learning and memory,(59,60) whereas chronic stress and chronic elevation of cortisol levels impair memory and cognition.(61,62) Electroconvulsive therapy causes a sharp increase in cortisol levels.”
BackgroundThe cognitive effects of electroconvulsive therapy in community settings
Sackeim, H. A., Prudic, J., Fuller, R., Keilp, J., Lavori, P. W., & Olfson, M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301180 · Cited by 577 · cited 1×
“Whereas the anterograde amnestic deficits are generally mild and transient, there is evidence that some degree of permanent retrograde amnesia may occur.(1) Although the therapeutic efficacy of ECT does not depend on the production of cognitive impairment, more effective forms of ECT, such as those delivered with bila…”
BackgroundDe Quervain, D. J. ‐., Henke, K., Aerni, A., Treyer, V., McGaugh, J. L., Berthold, T., Nitsch, R. M., Buck, A., Roozendaal, B., & Hock, C. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02542.x · Cited by 342
An open label trial of C-1073 (mifepristone) for psychotic major depression*
Belanoff, J. K., Rothschild, A. J., Cassidy, F., DeBattista, C., Baulieu, E.-E., Schold, C., & Schatzberg, A. F. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01432-4 · Cited by 320
Young, A. H., Gallagher, P., Watson, S., Del-Estal, D., Owen, B. M., & Nicol Ferrier, I. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300471 · Cited by 318 · cited 1×
“Mifepristone has also been found to reduce depression and improve cognition in bipolar disorder.(74)”
BackgroundNew insights into the role of cortisol and the glucocorticoid receptor in severe depression
Gold, P. W., Drevets, W. C., Charney, D. S., & Drevets, W. C. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01480-4 · Cited by 219
Attenuation of ECS-Induced Retrograde Amnesia by Using an Herbal Formulation
Vinekar, A. S., Andrade, C., Sriprada, V. T., George, J., Joseph, T., & Chandra, J. S. (1998) · The Journal of ECT · doi:10.1097/00124509-199806000-00004 · Cited by 16
Self-citation
Cited by
Adverse effects of electroconvulsive therapy
Andrade, C., Arumugham, S. S., & Thirthalli, J. (2016) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2016.04.004 · Cited by 216
Self-citationKey updates in the clinical application of electroconvulsive therapy
Weiner, R. D., & Reti, I. M. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1309362 · Cited by 166
A comparison of RUL ultrabrief pulse (0.3 ms) ECT and standard RUL ECT
Loo, C. K., Sainsbury, K., Sheehan, P., & Lyndon, B. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009292 · Cited by 127
Self-citation
Metadata
- Authors
- Pigot, M., Andrade, C., & FRANZCP, C. L.
- Venue
- The Journal of ECT
- Published
- 2008-03
- Volume
- 24
- Issue
- 1
- Pages
- 57-67
- ISSN
- 1095-0680 (ISSN-L)
- OpenAlex
- W1970779588
- Cited by
- 57
- References
- 8
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacological Attenuation of Electroconvulsive Therapy-Induced Cognitive Deficits: Theoretical Background and Clinical Findings. https://app.cochat.ai/papers/10.1097/yct.0b013e3181616c14
- The paper
- Pigot, M., Andrade, C., & FRANZCP, C. L. (2008). Pharmacological Attenuation of Electroconvulsive Therapy-Induced Cognitive Deficits: Theoretical Background and Clinical Findings. The Journal of ECT. https://doi.org/10.1097/yct.0b013e3181616c14
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.